Agree Itsa, ANP is the dark horse that has bolted to the lead.. one trial away from commercialisation and a $100M voucher waiting to fast track the drug to market. Big Pharma knows all too well that Gene Therapy is failing on its own and I believe there is a bidding war going on behind closed doors to see who will partner this micro cap into the big league. Billions of dollars at stake and numerous indications that require a solution for inflammation. Once we have approval for the Ph2b trial the SP will rally like we have never seen before.. so excited for the next few months.. insto's still busily accumulating and manipulating the SP.. DONT SELL!!! this rocket is about to take off..
Add to My Watchlist
What is My Watchlist?
